Dichain Structure of Botulinum Neurotoxin: Identification of Cleavage Sites in Types C, D, and F Neurotoxin Molecules

被引:0
|
作者
Yoshimasa Sagane
Toshihiro Watanabe
Hirokazu Kouguchi
Hiroyuki Sunagawa
Kaoru Inoue
Yukako Fujinaga
Keiji Oguma
Tohru Ohyama
机构
[1] Tokyo University of Agriculture,Department of Food Science, Faculty of Bioindustry
[2] Hokkaido Institute of Public Health,Department of Bacteriology
[3] Okayama University Medical School,undefined
来源
关键词
Botulinum neurotoxin; N-terminal amino acid sequence; C-terminal amino acid sequence; surface probability;
D O I
暂无
中图分类号
学科分类号
摘要
Botulinum neurotoxin (NT) is synthesized by Clostridium botulinum as about a 150-kDa single-chain polypeptide. Posttranslational modification by bacterial or exogenous proteases yielded dichain structure which formed a disulfide loop connecting a 50-kDa light chain (Lc) and 100-kDa heavy chain (Hc). We determined amino acid sequences around cleavage sites in the loop region of botulinum NTs produced by type C strain Stockholm, type D strain CB16, and type F strain Oslo by analysis of the C-terminal sequence of Lc and the N-terminal sequence of Hc. Cleavage was found at one or two sites at Arg444/Ser445 and Lys449/Thr450 for type C, and Lys442/Asn443 and Arg445/Asp446 for type D, respectively. In culture fluid of mildly proteolytic strains of type C and D, therefore, NT exists as a mixture of at least three forms of nicked dichain molecules. The NT of type F proteolytic strain Oslo showed the Arg435 as a C-terminal residue of Lc and Ala440 as an N-terminal residue of Hc, indicating that the bacterial protease cuts twice (Arg435/Lys436 and Lys439/Ala440), with excision of four amino acid residues. The location of cleavage and number of amino acid residue excisions in the loop region could be explained by the degree of exposure of amino acid residues on the surface of the molecule, which was predicted as surface probability from the amino acid sequence. In addition, the observed correlation may also be adapted to the cleavage sites of the other botulinum toxin types, A, B, E, and G.
引用
收藏
页码:885 / 892
页数:7
相关论文
共 50 条
  • [1] Dichain structure of botulinum neurotoxin: Identification of cleavage sites in types C, D, and F neurotoxin molecules
    Sagane, Y
    Watanabe, T
    Kouguchi, H
    Sunagawa, H
    Inoue, K
    Fujinaga, Y
    Oguma, K
    Ohyama, T
    JOURNAL OF PROTEIN CHEMISTRY, 1999, 18 (08): : 885 - 892
  • [2] Immunomagnetic beads assay for the detection of botulinum neurotoxin types C and D
    Gessler, Frank
    Hampe, Katrin
    Schmidt, Michaela
    Boehnel, Helge
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 56 (03) : 225 - 232
  • [3] Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D
    Tsukamoto, Kentaro
    Kozai, Yuiko
    Ihara, Hideshi
    Kohda, Tomoko
    Mukamoto, Masafumi
    Tsuji, Takao
    Kozaki, Shunji
    MICROBIAL PATHOGENESIS, 2008, 44 (06) : 484 - 493
  • [4] Sensitive detection of botulinum neurotoxin types C and D with an immunoaffinity chromatographic column test
    Gessler, F
    Hampe, K
    Böhnel, H
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2005, 71 (12) : 7897 - 7903
  • [5] Identification of a second receptor binding site in Botulinum Neurotoxin F
    Dehn, Christopher
    Krez, Nadja
    Weisemann, Jasmin
    Mahrhold, Stefan
    Binz, Thomas
    Rummel, Andreas
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 : S34 - S34
  • [6] Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5
    Kalb, S. R.
    Baudys, J.
    Webb, R. P.
    Wright, P.
    Smith, T. J.
    Smith, L. A.
    Fernandez, R.
    Raphael, B. H.
    Maslanka, S. E.
    Barr, J. R.
    TOXICON, 2013, 68 : 76 - 77
  • [7] Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5
    Kalb, Suzanne R.
    Baudys, Jakub
    Webb, Robert P.
    Wright, Patrick
    Smith, Theresa J.
    Smith, Leonard A.
    Fernandez, Rafael
    Raphael, Brian H.
    Maslanka, Susan E.
    Pirkle, James L.
    Barr, John R.
    FEBS LETTERS, 2012, 586 (02) : 109 - 115
  • [8] The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites
    Strotmeier, Jasmin
    Gu, Shenyan
    Jutzi, Stephan
    Mahrhold, Stefan
    Zhou, Jie
    Pich, Andreas
    Eichner, Timo
    Bigalke, Hans
    Rummel, Andreas
    Jin, Rongsheng
    Binz, Thomas
    MOLECULAR MICROBIOLOGY, 2011, 81 (01) : 143 - 156
  • [9] Immune response of horses to vaccination with the recombinant Hc domain of botulinum neurotoxin types C and D
    Stahl, Christina
    Unger, Lucia
    Mazuet, Christelle
    Popoff, Michel
    Straub, Reto
    Frey, Joachim
    VACCINE, 2009, 27 (41) : 5661 - 5666
  • [10] Production and Evaluation of a Recombinant Chimeric Vaccine against Clostridium botulinum Neurotoxin Types C and D
    Gil, Luciana A. F.
    da Cunha, Carlos Eduardo P.
    Moreira, Gustavo M. S. G.
    Salvarani, Felipe M.
    Assis, Ronnie A.
    Lobato, Francisco Carlos F.
    Mendonca, Marcelo
    Dellagostin, Odir A.
    Conceicao, Fabricio R.
    PLOS ONE, 2013, 8 (07):